FDAFDA · Food and drugs·Recall number D-0257-2026
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
Published January 21, 2026 · Recall initiated: November 26, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CLINDAMYCIN PHOSPHATE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Nationwide in the USA.
- UPC
- 0351672408138
- Lot
- Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.